Form 4: Merck EVP & CFO Caroline Litchfield Reports Acquisition of 23,432 Shares Following Performance Share Unit Payout

Caroline Litchfield, EVP & CFO of Merck & Co., Inc., acquired 23,432 shares of common stock on January 27, 2025, following the satisfaction of performance criteria for performance share units.

Summary

• On January 27, 2025, Caroline Litchfield, the EVP & CFO of Merck & Co., Inc., acquired 23,432 shares of Merck's common stock.
• The acquisition was a result of the satisfaction of performance criteria for performance share units granted on March 31, 2022.
• The performance shares were paid out at 169 percent of the target awards and include dividends accrued over the three-year performance period ending December 31, 2024.
• The price per share was $97.94.
• Following the transaction, Litchfield directly owns 74,340.194 shares of Merck common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the acquisition of shares by the CFO, resulting from the vesting of performance share units above target, suggests confidence in the company's performance and future prospects.

Positives

• The vesting of performance share units at 169% suggests strong company performance over the three-year performance period.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates the acquisition of shares by a key executive, which can be interpreted as a sign of confidence in the company's future performance.

Stakeholder Impact

• The acquisition of shares by a key executive could positively influence shareholder sentiment.

Key Dates